Answers are grounded in this paper and cite their sources.
Immune checkpoint inhibitors (CPIs) are used in cancer patients to enhance the activity of the immune system against tumor cells. They exert their actions by inhibiting negative regulatory molecule...
No takes yet. Share an insight, caveat, or question.
Erol-Yıldız et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: